Sagent Pharmaceuticals, Inc.

CIK 1369786 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sagent Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2017SC 13G/A0001144204-17-008190
Sep 9, 201615-12B0001193125-16-705997
Sep 2, 2016EFFECT9999999995-16-005592
Sep 2, 2016SC 13G/A0000904454-16-001429
Sep 1, 201640000904454-16-001413
Sep 1, 201640000904454-16-001415
Aug 31, 201640000899243-16-028304
Aug 31, 201640000899243-16-028294
Aug 31, 201640000899243-16-028313
Aug 31, 201640000899243-16-028311
Aug 31, 201640000899243-16-028314
Aug 31, 201640000899243-16-028308
Aug 31, 201640000899243-16-028295
Aug 31, 201640000899243-16-028315
Aug 31, 201640000899243-16-028300
Aug 31, 201640000899243-16-028310
Aug 31, 201640000899243-16-028302
Aug 31, 201640000899243-16-028303
Aug 30, 2016S-8 POS0001193125-16-696716
Aug 30, 2016POS AM0001193125-16-696706
Aug 29, 201625-NSE0001354457-16-000473
Aug 29, 20168-K0001193125-16-695556
Aug 29, 2016SC TO-T/A0001193125-16-694525
Aug 29, 2016SC 14D9/A0001193125-16-695543
Aug 24, 2016SC TO-T/A0001193125-16-689420